Literature DB >> 26976954

STAT3 Impairs STAT5 Activation in the Development of IL-9-Secreting T Cells.

Matthew R Olson1, Felipe Fortino Verdan2, Matthew M Hufford3, Alexander L Dent4, Mark H Kaplan5.   

Abstract

Th cell subsets develop in response to multiple activating signals, including the cytokine environment. IL-9-secreting T cells develop in response to the combination of IL-4 and TGF-β, although they clearly require other cytokine signals, leading to the activation of transcription factors including STAT5. In Th17 cells, there is a molecular antagonism of STAT5 with STAT3 signaling, although whether this paradigm exists in other Th subsets is not clear. In this paper, we demonstrate that STAT3 attenuates the ability of STAT5 to promote the development of IL-9-secreting T cells. We demonstrate that production of IL-9 is increased in the absence of STAT3 and cytokines that result in a sustained activation of STAT3, including IL-6, have the greatest potency in repressing IL-9 production in a STAT3-dependent manner. Increased IL-9 production in the absence of STAT3 correlates with increased endogenous IL-2 production and STAT5 activation, and blocking IL-2 responses eliminates the difference in IL-9 production between wild-type and STAT3-deficient T cells. Moreover, transduction of developing Th9 cells with a constitutively active STAT5 eliminates the ability of IL-6 to reduce IL-9 production. Thus, STAT3 functions as a negative regulator of IL-9 production through attenuation of STAT5 activation and function.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26976954      PMCID: PMC4821742          DOI: 10.4049/jimmunol.1501801

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

1.  Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells.

Authors:  Chi-Keung Wan; Allison B Andraski; Rosanne Spolski; Peng Li; Majid Kazemian; Jangsuk Oh; Leigh Samsel; Phillip A Swanson; Dorian B McGavern; Elizabeth P Sampaio; Alexandra F Freeman; Joshua D Milner; Steven M Holland; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

Review 2.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

3.  TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression.

Authors:  V L Heath; E E Murphy; C Crain; M G Tomlinson; A O'Garra
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

4.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

5.  Opposing actions of IL-2 and IL-21 on Th9 differentiation correlate with their differential regulation of BCL6 expression.

Authors:  Wei Liao; Rosanne Spolski; Peng Li; Ning Du; Erin E West; Min Ren; Suman Mitra; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

6.  IL-2 dependence of IL-9 expression in human T lymphocytes.

Authors:  F A Houssiau; J C Renauld; W E Fibbe; J Van Snick
Journal:  J Immunol       Date:  1992-05-15       Impact factor: 5.422

7.  Alternative activation of STAT1 and STAT3 in response to interferon-gamma.

Authors:  Yulan Qing; George R Stark
Journal:  J Biol Chem       Date:  2004-07-27       Impact factor: 5.157

8.  BCL6 controls Th9 cell development by repressing Il9 transcription.

Authors:  Ribal Bassil; William Orent; Marta Olah; Ahmed T Kurdi; Michael Frangieh; Thomas Buttrick; Samia J Khoury; Wassim Elyaman
Journal:  J Immunol       Date:  2014-05-30       Impact factor: 5.422

9.  Stat5 activation plays a critical role in Th2 differentiation.

Authors:  Jinfang Zhu; Javier Cote-Sierra; Liying Guo; William E Paul
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

10.  The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.

Authors:  Arianne C Richard; Cuiyan Tan; Eric T Hawley; Julio Gomez-Rodriguez; Ritobrata Goswami; Xiang-Ping Yang; Anthony C Cruz; Pallavi Penumetcha; Erika T Hayes; Martin Pelletier; Odile Gabay; Matthew Walsh; John R Ferdinand; Andrea Keane-Myers; Yongwon Choi; John J O'Shea; Aymen Al-Shamkhani; Mark H Kaplan; Igal Gery; Richard M Siegel; Françoise Meylan
Journal:  J Immunol       Date:  2015-03-18       Impact factor: 5.422

View more
  18 in total

1.  Inhibition of IL-2 responsiveness by IL-6 is required for the generation of GC-TFH cells.

Authors:  Amber Papillion; Michael D Powell; Danielle A Chisolm; Holly Bachus; Michael J Fuller; Amy S Weinmann; Alejandro Villarino; John J O'Shea; Beatriz León; Kenneth J Oestreich; André Ballesteros-Tato
Journal:  Sci Immunol       Date:  2019-09-13

2.  Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production.

Authors:  Matthew R Olson; Benjamin J Ulrich; Sarah A Hummel; Ibrahim Khan; Brice Meuris; Yesesri Cherukuri; Alexander L Dent; Sarath Chandra Janga; Mark H Kaplan
Journal:  J Immunol       Date:  2017-05-03       Impact factor: 5.422

Review 3.  The transcription factor network in Th9 cells.

Authors:  Mark H Kaplan
Journal:  Semin Immunopathol       Date:  2016-11-11       Impact factor: 9.623

4.  Cutting Edge: The Expression of Transcription Inhibitor GFI1 Is Induced by Retinoic Acid to Rein in Th9 Polarization.

Authors:  Leon Friesen; Raymond Kostlan; Qingyang Liu; Hao Yu; Jinfang Zhu; Nicholas Lukacs; Chang H Kim
Journal:  J Immunol       Date:  2022-09-02       Impact factor: 5.426

Review 5.  IL-9-producing T cells: potential players in allergy and cancer.

Authors:  Pornpimon Angkasekwinai; Chen Dong
Journal:  Nat Rev Immunol       Date:  2020-08-12       Impact factor: 53.106

6.  STAT3 Activation Impairs the Stability of Th9 Cells.

Authors:  Benjamin J Ulrich; Felipe Fortino Verdan; Andrew N J McKenzie; Mark H Kaplan; Matthew R Olson
Journal:  J Immunol       Date:  2017-01-30       Impact factor: 5.422

7.  IL-9 Producing Tumor-Infiltrating Lymphocytes and Treg Subsets Drive Immune Escape of Tumor Cells in Non-Small Cell Lung Cancer.

Authors:  Lisanne Heim; Zuqin Yang; Patrick Tausche; Katja Hohenberger; Mircea T Chiriac; Julia Koelle; Carol-Immanuel Geppert; Katerina Kachler; Sarah Miksch; Anna Graser; Juliane Friedrich; Rakshin Kharwadkar; Ralf J Rieker; Denis I Trufa; Horia Sirbu; Markus F Neurath; Mark H Kaplan; Susetta Finotto
Journal:  Front Immunol       Date:  2022-04-20       Impact factor: 8.786

8.  Specifically differentiated T cell subset promotes tumor immunity over fatal immunity.

Authors:  Abdulraouf Ramadan; Brad Griesenauer; Djamilatou Adom; Reuben Kapur; Helmut Hanenberg; Chen Liu; Mark H Kaplan; Sophie Paczesny
Journal:  J Exp Med       Date:  2017-10-16       Impact factor: 14.307

Review 9.  STAT5 and CD4 + T Cell Immunity.

Authors:  David L Owen; Michael A Farrar
Journal:  F1000Res       Date:  2017-01-11

10.  STAT5 Represses a STAT3-Independent Th17-like Program during Th9 Cell Differentiation.

Authors:  D Alejandro Canaria; Bingyu Yan; Maia G Clare; Zonghao Zhang; Grace A Taylor; David L Boone; Majid Kazemian; Matthew R Olson
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.